Magnesium pidolate: Difference between revisions
Appearance
Content deleted Content added
m Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script) |
M97uzivatel (talk | contribs) No edit summary |
||
(11 intermediate revisions by 10 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = 400295046 |
| verifiedrevid = 400295046 |
||
Line 25: | Line 26: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number = |
| CAS_number = 135701-98-3 |
||
| ATC_prefix = A12 |
| ATC_prefix = A12 |
||
| ATC_suffix = CC08 |
| ATC_suffix = CC08 |
||
Line 33: | Line 34: | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 8014340 |
| ChemSpiderID = 8014340 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = V5PC588N7G |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=10 | H=12 | N=2 | Mg=1 | O=6 |
| C=10 | H=12 | N=2 | Mg=1 | O=6 |
||
| molecular_weight = 280.517 g/mol |
|||
| smiles = [Mg+2].[O-]C(=O)C1NC(=O)CC1.[O-]C(=O)C1NC(=O)CC1 |
| smiles = [Mg+2].[O-]C(=O)C1NC(=O)CC1.[O-]C(=O)C1NC(=O)CC1 |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
Line 44: | Line 46: | ||
}} |
}} |
||
'''Magnesium pidolate''', the [[magnesium]] [[salt (chemistry)|salt]] of [[pidolic acid]] (pyroglutamic acid), is a [[Dietary mineral|mineral supplement]]. |
'''Magnesium pidolate''', the [[magnesium]] [[salt (chemistry)|salt]] of [[pidolic acid]] (also known as pyroglutamic acid), is a [[Dietary mineral|mineral supplement]], which contains 8.6% magnesium w/w. |
||
==External links== |
==External links== |
||
* {{cite journal |vauthors=De Franceschi L, Bachir D, Galacteros F, etal |title=Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease |journal=Br. J. Haematol. |volume=108 |issue=2 |pages=284–9 |year=2000 |pmid=10691856 |doi=10.1046/j.1365-2141.2000.01861.x}} |
* {{cite journal |vauthors=De Franceschi L, Bachir D, Galacteros F, etal |title=Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease |journal=Br. J. Haematol. |volume=108 |issue=2 |pages=284–9 |year=2000 |pmid=10691856 |doi=10.1046/j.1365-2141.2000.01861.x|s2cid=36974114 |doi-access= }} |
||
{{Mineral supplements}} |
{{Mineral supplements}} |
||
⚫ | |||
[[Category:Magnesium compounds]] |
[[Category:Magnesium compounds]] |
||
[[Category:Salts |
[[Category:Salts of carboxylic acids]] |
||
⚫ |
Latest revision as of 08:04, 19 April 2024
Clinical data | |
---|---|
AHFS/Drugs.com | Consumer Drug Information |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.080.955 |
Chemical and physical data | |
Formula | C10H12MgN2O6 |
Molar mass | 280.519 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Magnesium pidolate, the magnesium salt of pidolic acid (also known as pyroglutamic acid), is a mineral supplement, which contains 8.6% magnesium w/w.